BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15865813)

  • 1. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutism - from diagnosis to use of antiandrogens.
    Unluhizarci K; Karaca Z; Kelestimur F
    Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
    Mitkov M; Pekhlivanov B; Terzieva D
    Akush Ginekol (Sofiia); 2004; 43(3):34-7. PubMed ID: 15341255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
    Zemtsov A; Wilson L
    Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiandrogen therapy in the polycystic ovary syndrome].
    Messina M; Milani P; Gentile L; Gellona A; Monaco A; Manieri C
    Minerva Endocrinol; 1987; 12(3):231-8. PubMed ID: 3657744
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
    Prelević GM; Puzigaća Z; Balint-Perić LA
    Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
    Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
    J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V
    Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of commonly used medical treatments for hirsutism in women.
    Koulouri O; Conway GS
    Clin Endocrinol (Oxf); 2008 May; 68(5):800-5. PubMed ID: 17980017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Finasteride and flutamide in the treatment of hirsutism].
    Falsetti L; De Fusco D; Rosina B
    Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.